Fingerprint
Dive into the research topics of 'Phase II study of MLN8237 (Alisertib) in advanced/ metastatic sarcoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II study of MLN8237 (Alisertib) in advanced/ metastatic sarcoma
Mark A. Dickson, M. R. Mahoney, W. D. Tap, S. P. D'Angelo, M. L. Keohan, B. A. Van Tine, M. Agulnik, L. E. Horvath, J. S. Nair, G. K. Schwartz
Research output: Contribution to journal › Article › peer-review
62
Scopus
citations